Nepal | September 24, 2020

Serum Institute gets approval to resume Indian trial of AstraZeneca COVID vaccine: source

Reuters
Share Now:

MUMBAI/BENGALURU: Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca’s potential COVID-19 vaccine, a source familiar with the matter said on Wednesday.

The approval came from the Drugs Controller General of India, the source said.

AstraZeneca has resumed British clinical trials of the vaccine – one of the most advanced in development for COVID-19 – after they were paused earlier this month following a serious side effect in a trial participant.

Trials have also resumed in Brazil and South Africa.

The trial remains on hold in the United States, the U.S. Food and Drug Administration’s top official confirmed on Tuesday.

Serum, the world’s biggest vaccine manufacturer, did not immediately respond to Reuters’ requests for comment. The DCGI did not return an email seeking comment.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Nepal denies claims of construction by Chinese side within its territory

KATHMANDU: The Ministry of Foreign Affairs (MoFA) has denied claims of construction of buildings by China within Nepali territory between Nepal-China boundary pillars. Issuing a statement on Wednesday, MoFA stated that it has taken note of media reports on alleged construction between Nepal-China Read More...

Chinese encroachment in Humla? China denies it, so does MoFA

Buildings have been built at a distance of around two kilometres from the border in Lapcha Limi area of Namkha Rural Municipality in Humla: NC lawmaker Rangamati Shahi KATHMANDU, SEPTEMBER 23 China has allegedly built at least nine buildings on Nepali land near Nepal-China border in Humla distri Read More...

Supreme Court tells government not to induct Gautam in Cabinet

KATHMANDU, SEPTEMBER 23 The Supreme Court today ordered the government not to induct Bamdev Gautam in the Cabinet or assign him any such post till the apex court issued another order in the case. Gautam was recently nominated to the National Assembly by the president on the government’s recommend Read More...

Overnight wait for PCR test for scores

KATHMANDU, SEPTEMBER 23 Sukraraj Tropical and Infectious Disease Hospital at Teku has been seeing a surge in the number of people visiting the hospital for polymerase chain reaction test. The number of people visiting the hospital for the tests has drastically increased after the government al Read More...

Surge in covid patients requiring ventilator support across Nepal

KATHMANDU, SEPTEMBER 23 There has been a steady rise in the number of patients, who need ventilator support and intensive care in the course of treatment of the coronavirus disease, across the country. According to the Ministry of Health and Population, 43 persons have been given ventilator ca Read More...

Mountaineer Ang Rita Sherpa cremated

KATHMANDU, SEPTEMBER 23 Hundreds of government officials, mountaineers, fellow Sherpa guides and supporters gathered in Nepal today to mourn the veteran guide who scaled Mount Everest 10 times without supplimentary oxygen. The body of Ang Rita was cremated today according to Buddhist ritua Read More...

Rainfall likely to continue for three more days

KATHMANDU, SEPTEMBER 23 The Meteorological Forecasting Division has predicted moderate to heavy rainfall with thunder and lightning throughout the country till Saturday. “A low-pressure area is now located over Chhattisgarh state of India and is advancing to the west and north-west of Nepal, Read More...

Government issues procedure to establish information, record centre at local levels

KATHMANDU, SEPTEMBER 23 The Government of Nepal has issued ‘Procedure on Establishment and Operation of Information and Records Centre’ for local levels. The procedure will come into effect after it is passed by the executive of the concerned local unit. It aims to make the service deliver Read More...